The global Anti-Peptic Ulcer Drugs market was valued at US$ 8713 million in 2023 and is anticipated to reach US$ 21220 million by 2030, witnessing a CAGR of 13.4% during the forecast period 2024-2030.

Anti-Peptic Ulcer Drugs Market

Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.

Global Anti-Peptic Ulcer Drugs key players include AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, etc. Global top five players hold a share about 50%.

In terms of product, the segment includes Proton Pump Inhibitors (PPIs), Potassium-Competitive Acid Blockers (P-CAB), Antacids, H2 Antagonists, Ulcer Protective Drugs. And in terms of application, the application includes Gastritis, Gastric Ulcers, Duodenal Ulcers, Gastroesophageal Reflux Disease (GERD).

This report aims to provide a comprehensive presentation of the global market for Anti-Peptic Ulcer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Peptic Ulcer Drugs.

Report Scope

The Anti-Peptic Ulcer Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Peptic Ulcer Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anti-Peptic Ulcer Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Anti-Peptic Ulcer Drugs Market Report

Report Metric	Details
Report Name	Anti-Peptic Ulcer Drugs Market
Accounted market size in 2023	US$ 8713 million
Forecasted market size in 2030	US$ 21220 million
CAGR	13.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Proton Pump Inhibitors (PPIs) Potassium-Competitive Acid Blockers (P-CAB) Antacids H2 Antagonists Ulcer Protective Drugs
Segment by Application	Gastritis Gastric Ulcers Duodenal Ulcers Gastroesophageal Reflux Disease (GERD)
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, Huadong Medicine, Changzhou Siyao, Beijing Yuekang, Guangdong Dahua, Xian Janssen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-Peptic Ulcer Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Anti-Peptic Ulcer Drugs Market growing?

Ans: The Anti-Peptic Ulcer Drugs Market witnessing a CAGR of 13.4% during the forecast period 2024-2030.

What is the Anti-Peptic Ulcer Drugs Market size in 2030?

Ans: The Anti-Peptic Ulcer Drugs Market size in 2030 will be US$ 21220 million.

What is the market share of major companies in Anti-Peptic Ulcer Drugs Market?

Ans: Global top five players hold a share about 50%.

Who are the main players in the Anti-Peptic Ulcer Drugs Market report?

Ans: The main players in the Anti-Peptic Ulcer Drugs Market are AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, Huadong Medicine, Changzhou Siyao, Beijing Yuekang, Guangdong Dahua, Xian Janssen

What are the Application segmentation covered in the Anti-Peptic Ulcer Drugs Market report?

Ans: The Applications covered in the Anti-Peptic Ulcer Drugs Market report are Gastritis, Gastric Ulcers, Duodenal Ulcers, Gastroesophageal Reflux Disease (GERD)

What are the Type segmentation covered in the Anti-Peptic Ulcer Drugs Market report?

Ans: The Types covered in the Anti-Peptic Ulcer Drugs Market report are Proton Pump Inhibitors (PPIs), Potassium-Competitive Acid Blockers (P-CAB), Antacids, H2 Antagonists, Ulcer Protective Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Proton Pump Inhibitors (PPIs)

1.2.3 Potassium-Competitive Acid Blockers (P-CAB)

1.2.4 Antacids

1.2.5 H2 Antagonists

1.2.6 Ulcer Protective Drugs

1.3 Market by Application

1.3.1 Global Anti-Peptic Ulcer Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Gastritis

1.3.3 Gastric Ulcers

1.3.4 Duodenal Ulcers

1.3.5 Gastroesophageal Reflux Disease (GERD)

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Anti-Peptic Ulcer Drugs Market Perspective (2019-2030)

2.2 Anti-Peptic Ulcer Drugs Growth Trends by Region

2.2.1 Global Anti-Peptic Ulcer Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Anti-Peptic Ulcer Drugs Historic Market Size by Region (2019-2024)

2.2.3 Anti-Peptic Ulcer Drugs Forecasted Market Size by Region (2025-2030)

2.3 Anti-Peptic Ulcer Drugs Market Dynamics

2.3.1 Anti-Peptic Ulcer Drugs Industry Trends

2.3.2 Anti-Peptic Ulcer Drugs Market Drivers

2.3.3 Anti-Peptic Ulcer Drugs Market Challenges

2.3.4 Anti-Peptic Ulcer Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Anti-Peptic Ulcer Drugs Players by Revenue

3.1.1 Global Top Anti-Peptic Ulcer Drugs Players by Revenue (2019-2024)

3.1.2 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Anti-Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Anti-Peptic Ulcer Drugs Revenue

3.4 Global Anti-Peptic Ulcer Drugs Market Concentration Ratio

3.4.1 Global Anti-Peptic Ulcer Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Anti-Peptic Ulcer Drugs Revenue in 2023

3.5 Anti-Peptic Ulcer Drugs Key Players Head office and Area Served

3.6 Key Players Anti-Peptic Ulcer Drugs Product Solution and Service

3.7 Date of Enter into Anti-Peptic Ulcer Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-Peptic Ulcer Drugs Breakdown Data by Type

4.1 Global Anti-Peptic Ulcer Drugs Historic Market Size by Type (2019-2024)

4.2 Global Anti-Peptic Ulcer Drugs Forecasted Market Size by Type (2025-2030)

5 Anti-Peptic Ulcer Drugs Breakdown Data by Application

5.1 Global Anti-Peptic Ulcer Drugs Historic Market Size by Application (2019-2024)

5.2 Global Anti-Peptic Ulcer Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Anti-Peptic Ulcer Drugs Market Size (2019-2030)

6.2 North America Anti-Peptic Ulcer Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Anti-Peptic Ulcer Drugs Market Size by Country (2019-2024)

6.4 North America Anti-Peptic Ulcer Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Anti-Peptic Ulcer Drugs Market Size (2019-2030)

7.2 Europe Anti-Peptic Ulcer Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Anti-Peptic Ulcer Drugs Market Size by Country (2019-2024)

7.4 Europe Anti-Peptic Ulcer Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Anti-Peptic Ulcer Drugs Market Size (2019-2030)

8.2 Asia-Pacific Anti-Peptic Ulcer Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Anti-Peptic Ulcer Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific Anti-Peptic Ulcer Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Anti-Peptic Ulcer Drugs Market Size (2019-2030)

9.2 Latin America Anti-Peptic Ulcer Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Anti-Peptic Ulcer Drugs Market Size by Country (2019-2024)

9.4 Latin America Anti-Peptic Ulcer Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Anti-Peptic Ulcer Drugs Market Size (2019-2030)

10.2 Middle East & Africa Anti-Peptic Ulcer Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Company Detail

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Introduction

11.1.4 AstraZeneca Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024)

11.1.5 AstraZeneca Recent Development

11.2 Ask-pharm

11.2.1 Ask-pharm Company Detail

11.2.2 Ask-pharm Business Overview

11.2.3 Ask-pharm Anti-Peptic Ulcer Drugs Introduction

11.2.4 Ask-pharm Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024)

11.2.5 Ask-pharm Recent Development

11.3 Takeda

11.3.1 Takeda Company Detail

11.3.2 Takeda Business Overview

11.3.3 Takeda Anti-Peptic Ulcer Drugs Introduction

11.3.4 Takeda Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024)

11.3.5 Takeda Recent Development

11.4 Yangtze River Pharm

11.4.1 Yangtze River Pharm Company Detail

11.4.2 Yangtze River Pharm Business Overview

11.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Introduction

11.4.4 Yangtze River Pharm Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024)

11.4.5 Yangtze River Pharm Recent Development

11.5 Shandong Luoxin

11.5.1 Shandong Luoxin Company Detail

11.5.2 Shandong Luoxin Business Overview

11.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Introduction

11.5.4 Shandong Luoxin Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024)

11.5.5 Shandong Luoxin Recent Development

11.6 Huadong Medicine

11.6.1 Huadong Medicine Company Detail

11.6.2 Huadong Medicine Business Overview

11.6.3 Huadong Medicine Anti-Peptic Ulcer Drugs Introduction

11.6.4 Huadong Medicine Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024)

11.6.5 Huadong Medicine Recent Development

11.7 Changzhou Siyao

11.7.1 Changzhou Siyao Company Detail

11.7.2 Changzhou Siyao Business Overview

11.7.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Introduction

11.7.4 Changzhou Siyao Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024)

11.7.5 Changzhou Siyao Recent Development

11.8 Beijing Yuekang

11.8.1 Beijing Yuekang Company Detail

11.8.2 Beijing Yuekang Business Overview

11.8.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Introduction

11.8.4 Beijing Yuekang Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024)

11.8.5 Beijing Yuekang Recent Development

11.9 Guangdong Dahua

11.9.1 Guangdong Dahua Company Detail

11.9.2 Guangdong Dahua Business Overview

11.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Introduction

11.9.4 Guangdong Dahua Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024)

11.9.5 Guangdong Dahua Recent Development

11.10 Xian Janssen

11.10.1 Xian Janssen Company Detail

11.10.2 Xian Janssen Business Overview

11.10.3 Xian Janssen Anti-Peptic Ulcer Drugs Introduction

11.10.4 Xian Janssen Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024)

11.10.5 Xian Janssen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Astrazeneca plc

List of Tables

Table 1. Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Proton Pump Inhibitors (PPIs)

Table 3. Key Players of Potassium-Competitive Acid Blockers (P-CAB)

Table 4. Key Players of Antacids

Table 5. Key Players of H2 Antagonists

Table 6. Key Players of Ulcer Protective Drugs

Table 7. Global Anti-Peptic Ulcer Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Anti-Peptic Ulcer Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Anti-Peptic Ulcer Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Anti-Peptic Ulcer Drugs Market Share by Region (2019-2024)

Table 11. Global Anti-Peptic Ulcer Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Anti-Peptic Ulcer Drugs Market Share by Region (2025-2030)

Table 13. Anti-Peptic Ulcer Drugs Market Trends

Table 14. Anti-Peptic Ulcer Drugs Market Drivers

Table 15. Anti-Peptic Ulcer Drugs Market Challenges

Table 16. Anti-Peptic Ulcer Drugs Market Restraints

Table 17. Global Anti-Peptic Ulcer Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Anti-Peptic Ulcer Drugs Market Share by Players (2019-2024)

Table 19. Global Top Anti-Peptic Ulcer Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Peptic Ulcer Drugs as of 2023)

Table 20. Ranking of Global Top Anti-Peptic Ulcer Drugs Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Anti-Peptic Ulcer Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Anti-Peptic Ulcer Drugs Product Solution and Service

Table 24. Date of Enter into Anti-Peptic Ulcer Drugs Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Anti-Peptic Ulcer Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2019-2024)

Table 28. Global Anti-Peptic Ulcer Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2025-2030)

Table 30. Global Anti-Peptic Ulcer Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2019-2024)

Table 32. Global Anti-Peptic Ulcer Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2025-2030)

Table 34. North America Anti-Peptic Ulcer Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Anti-Peptic Ulcer Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Anti-Peptic Ulcer Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Anti-Peptic Ulcer Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Anti-Peptic Ulcer Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Anti-Peptic Ulcer Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Anti-Peptic Ulcer Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Anti-Peptic Ulcer Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Anti-Peptic Ulcer Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Anti-Peptic Ulcer Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Anti-Peptic Ulcer Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Anti-Peptic Ulcer Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Anti-Peptic Ulcer Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 49. AstraZeneca Company Detail

Table 50. AstraZeneca Business Overview

Table 51. AstraZeneca Anti-Peptic Ulcer Drugs Product

Table 52. AstraZeneca Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024) & (US$ Million)

Table 53. AstraZeneca Recent Development

Table 54. Ask-pharm Company Detail

Table 55. Ask-pharm Business Overview

Table 56. Ask-pharm Anti-Peptic Ulcer Drugs Product

Table 57. Ask-pharm Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024) & (US$ Million)

Table 58. Ask-pharm Recent Development

Table 59. Takeda Company Detail

Table 60. Takeda Business Overview

Table 61. Takeda Anti-Peptic Ulcer Drugs Product

Table 62. Takeda Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024) & (US$ Million)

Table 63. Takeda Recent Development

Table 64. Yangtze River Pharm Company Detail

Table 65. Yangtze River Pharm Business Overview

Table 66. Yangtze River Pharm Anti-Peptic Ulcer Drugs Product

Table 67. Yangtze River Pharm Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024) & (US$ Million)

Table 68. Yangtze River Pharm Recent Development

Table 69. Shandong Luoxin Company Detail

Table 70. Shandong Luoxin Business Overview

Table 71. Shandong Luoxin Anti-Peptic Ulcer Drugs Product

Table 72. Shandong Luoxin Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024) & (US$ Million)

Table 73. Shandong Luoxin Recent Development

Table 74. Huadong Medicine Company Detail

Table 75. Huadong Medicine Business Overview

Table 76. Huadong Medicine Anti-Peptic Ulcer Drugs Product

Table 77. Huadong Medicine Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024) & (US$ Million)

Table 78. Huadong Medicine Recent Development

Table 79. Changzhou Siyao Company Detail

Table 80. Changzhou Siyao Business Overview

Table 81. Changzhou Siyao Anti-Peptic Ulcer Drugs Product

Table 82. Changzhou Siyao Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024) & (US$ Million)

Table 83. Changzhou Siyao Recent Development

Table 84. Beijing Yuekang Company Detail

Table 85. Beijing Yuekang Business Overview

Table 86. Beijing Yuekang Anti-Peptic Ulcer Drugs Product

Table 87. Beijing Yuekang Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024) & (US$ Million)

Table 88. Beijing Yuekang Recent Development

Table 89. Guangdong Dahua Company Detail

Table 90. Guangdong Dahua Business Overview

Table 91. Guangdong Dahua Anti-Peptic Ulcer Drugs Product

Table 92. Guangdong Dahua Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024) & (US$ Million)

Table 93. Guangdong Dahua Recent Development

Table 94. Xian Janssen Company Detail

Table 95. Xian Janssen Business Overview

Table 96. Xian Janssen Anti-Peptic Ulcer Drugs Product

Table 97. Xian Janssen Revenue in Anti-Peptic Ulcer Drugs Business (2019-2024) & (US$ Million)

Table 98. Xian Janssen Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Anti-Peptic Ulcer Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Anti-Peptic Ulcer Drugs Market Share by Type: 2023 VS 2030

Figure 3. Proton Pump Inhibitors (PPIs) Features

Figure 4. Potassium-Competitive Acid Blockers (P-CAB) Features

Figure 5. Antacids Features

Figure 6. H2 Antagonists Features

Figure 7. Ulcer Protective Drugs Features

Figure 8. Global Anti-Peptic Ulcer Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Anti-Peptic Ulcer Drugs Market Share by Application: 2023 VS 2030

Figure 10. Gastritis Case Studies

Figure 11. Gastric Ulcers Case Studies

Figure 12. Duodenal Ulcers Case Studies

Figure 13. Gastroesophageal Reflux Disease (GERD) Case Studies

Figure 14. Anti-Peptic Ulcer Drugs Report Years Considered

Figure 15. Global Anti-Peptic Ulcer Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Anti-Peptic Ulcer Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Anti-Peptic Ulcer Drugs Market Share by Region: 2023 VS 2030

Figure 18. Global Anti-Peptic Ulcer Drugs Market Share by Players in 2023

Figure 19. Global Top Anti-Peptic Ulcer Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Peptic Ulcer Drugs as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Anti-Peptic Ulcer Drugs Revenue in 2023

Figure 21. North America Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Anti-Peptic Ulcer Drugs Market Share by Country (2019-2030)

Figure 23. United States Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Anti-Peptic Ulcer Drugs Market Share by Country (2019-2030)

Figure 27. Germany Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Anti-Peptic Ulcer Drugs Market Share by Region (2019-2030)

Figure 35. China Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Anti-Peptic Ulcer Drugs Market Share by Country (2019-2030)

Figure 43. Mexico Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Anti-Peptic Ulcer Drugs Market Share by Country (2019-2030)

Figure 47. Turkey Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Anti-Peptic Ulcer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. AstraZeneca Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2019-2024)

Figure 50. Ask-pharm Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2019-2024)

Figure 51. Takeda Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2019-2024)

Figure 52. Yangtze River Pharm Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2019-2024)

Figure 53. Shandong Luoxin Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2019-2024)

Figure 54. Huadong Medicine Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2019-2024)

Figure 55. Changzhou Siyao Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2019-2024)

Figure 56. Beijing Yuekang Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2019-2024)

Figure 57. Guangdong Dahua Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2019-2024)

Figure 58. Xian Janssen Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions